| Application no. and date | 09780938.8 (espacenet) (Federated) (European Patent Register), 20090722 | | Patent/reg. no. and date | DK/EP 2307007, 20140827 | | Publication date | 20110413 | | Priority no. and date | EP 08161005, 20080723 | | EP pub. no. and date |
EP 2307007 20110413 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/GP/149664 | | Inventor | WRIGHT, Timothy, 471 Puritan Road
Swampscott, Massachusetts 01907, US,
AHMED, Syed Sohail, Via Socino 56
I-53100 Siena, IT,
LONDEI, Marco, 410 Pearl Street
La Jolla, California 92037, US,
GERGELY, Peter, Auf der Wacht 14
CH-4104 Oberwil, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61P 21/00 (2006.01) | | Title | Sphingosin-1-phosphat-receptormodulatorer samt deres anvendelse til behandling af muskelinflammation | | Int. application no. | EP2009059440 | | Int. publication no. | WO2010010127 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
